vaccination schedule
Showing 1 - 25 of 6,493
COVID-19 Trial in Xuzhou (Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule, Two
Completed
- COVID-19
- Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule
- +11 more
-
Xuzhou, Jiangsu, ChinaSuining County Center for Disease Control and Prevention
Feb 22, 2022
Respiratory Tract Infections, Infections, Allergy Trial in Geneva (Measles-Mumps-Rubella vaccine (MMR))
Not yet recruiting
- Respiratory Tract Infections
- +3 more
- Measles-Mumps-Rubella vaccine (MMR)
-
Geneva, SwitzerlandUniversity Hospitals of Geneva
Feb 24, 2023
Influenza Trial (Reminder)
Not yet recruiting
- Influenza
- Reminder
- (no location specified)
Aug 6, 2022
Pneumococcal Vaccination in Chronic Lymphocytic Leukaemia
Recruiting
- Pneumococcal Infections
- +3 more
- Prevnar13
-
Amsterdam-Zuidoost, NetherlandsAmsterdam UMC Locatie AMC
Dec 3, 2021
Schistosomiasis Mansoni, Schistosomiasis Haematobium, Vaccination; Infection Trial in Saint Louis (Sm14 recombinant vaccine+
Recruiting
- Schistosomiasis Mansoni
- +2 more
- Sm14 recombinant vaccine+ GLA-SE adjuvant
-
Saint Louis, SenegalBiomedical Research Center EPLS
Dec 13, 2022
COVID-19 Trial in Bizerte, Ariana, Tunis (CoronaVac/CoronaVac, CoronaVac/BNT162b2)
Completed
- COVID-19
- CoronaVac/CoronaVac
- CoronaVac/BNT162b2
-
Bizerte, Mateur, Tunisia
- +4 more
Jan 4, 2023
Poliomyelitis, Vaccine Reaction Trial (Eupolio)
Not yet recruiting
- Poliomyelitis
- Vaccine Reaction
- Eupolio
- (no location specified)
Jun 23, 2022
Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in
Recruiting
- SARS-CoV2 Infection
- SARS-CoV2 Antibodies
- assessment of the anti-SARS-CoV-2 IgG antibody titer in 3-dose schedule
- assessment of the anti-SARS-CoV-2 IgG antibody titer in 2-dose schedule
-
Bydgoszcz, PolandDepartment of Transplantology and General Surgery, Dr. A. Jurasz
Dec 15, 2021
Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study
Active, not recruiting
- SARS-CoV2 Infection
- SARS-CoV2 Antibodies
- assessment of the anti-SARS-CoV-2 IgG antibody titer in 3-dose schedule
- assessment of the anti-SARS-CoV-2 IgG antibody titer in 2-dose schedule
-
Bydgoszcz, Kujawsko-Pomorskie, PolandCardiology Department, Dr. A. Jurasz University Hospital
Nov 4, 2021
Influenza, Respiratory Tract Infections Trial in Los Angeles (Text Message R/R with Direct Appointment Schedule Link, Text
Active, not recruiting
- Influenza
- Respiratory Tract Infections
- Text Message R/R with Direct Appointment Schedule Link
- +5 more
-
Los Angeles, CaliforniaUniversity of California LA
Nov 14, 2021
Hepatitis B Trial in Bobo-Dioulasso (birth dose vaccination against hepatitis B strategy)
Recruiting
- Hepatitis B
- birth dose vaccination against hepatitis B strategy
-
Bobo-Dioulasso, Dafra, Burkina Faso
- +1 more
Apr 19, 2022
Vaccine Response Impaired, Hepatitis B, Aging Trial in Goiânia (Standard vaccination schedule, Reinforced vaccination schedule)
Unknown status
- Vaccine Response Impaired
- +2 more
- Standard vaccination schedule
- Reinforced vaccination schedule
-
Goiânia, Goiás, BrazilKarlla Antonieta Amorim Caetano
Sep 4, 2020
COVID-19, Influenza Trial in Quzhou (Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose
Completed
- COVID-19
- Influenza
- Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.
- Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 14.
-
Quzhou, Zhejiang, ChinaKaihua county Center for Disease Control and Prevention
Jul 23, 2021
Immunization; Infection, Educational Problems, Information Seeking Behavior Trial in Jada (Information Provision)
Completed
- Immunization; Infection
- +2 more
- Information Provision
-
Jada, Adamawa, NigeriaJada Local Government Primary Health Care Development Agency
Jul 11, 2020
Prematurity, Vaccination, Meningococcal Disease Trial in Tooting (4CMenB Vaccine)
Completed
- Prematurity
- +2 more
- 4CMenB Vaccine
-
Tooting, London, United KingdomSt Georges University Hospital NHS Foundation Trust
Nov 30, 2020
Vaccine Reaction Trial in Bengaluru (Regimen 1, Regimen 2)
Recruiting
- Vaccine Reaction
- Regimen 1
- Regimen 2
-
Bengaluru, Karnataka, IndiaKempegowda Institute Of Medical Sciences Hospital and Research C
Oct 4, 2023
Quadrivalent Influenza Vaccine Immunization Schedule for
Completed
- GCP
- Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
-
Jinan, Shandong, ChinaKou Zengqiang
Oct 17, 2023
Poliomyelitis, Polio Trial in Dhaka, Gujranwala, Karachi (Sabin Strain Inactivated Poliovirus Vaccine)
Not yet recruiting
- Poliomyelitis
- Polio
- Sabin Strain Inactivated Poliovirus Vaccine
-
Dhaka, Bangladesh
- +2 more
Apr 28, 2023
COVID-19, COVID-19 Immunisation Trial in Decatur, Bethesda, Seattle (mRNA-1273)
Completed
- COVID-19
- COVID-19 Immunisation
- mRNA-1273
-
Decatur, Georgia
- +2 more
Jan 26, 2023
Malaria Trial in Maputo (RTS,S/AS02D and RTS,S/AS02A)
Completed
- Malaria
- RTS,S/AS02D and RTS,S/AS02A
-
Maputo, MozambiqueGSK Investigational Site
Dec 26, 2019
Ebola Virus Disease Trial in Goma, Kinshasa (Zabdeno® booster, Ervebo® booster)
Not yet recruiting
- Ebola Virus Disease
- Zabdeno® booster
- Ervebo® booster
-
Goma, Congo, The Democratic Republic of the
- +1 more
Nov 6, 2023
Hepatitis A Trial (Healive (hepatitis A vacine(human diploid cell), inactivated))
Not yet recruiting
- Hepatitis A
- Healive (hepatitis A vacine(human diploid cell), inactivated)
- (no location specified)
Sep 21, 2023
Norovirus Infections Trial in Cypress, New Orleans, Austin (VXA-GI.1.NN, Placebo Tablet)
Completed
- Norovirus Infections
- VXA-GI.1.NN
- Placebo Tablet
-
Cypress, California
- +2 more
Sep 19, 2022
Japanese Encephalitis Virus Disease Trial in Hohhot (Japanese Encephalitis Vaccine produced by IMBCAMS, Japanese Encephalitis
Active, not recruiting
- Japanese Encephalitis Virus Disease
- Japanese Encephalitis Vaccine produced by IMBCAMS
- Japanese Encephalitis Vaccine produced by Liaoning Chenda
-
Hohhot, Inner Mongolia Autonomous Region, ChinaDisease prevention and control center of Inner Mongolia autonomo
Mar 8, 2022
Coverage Of Rotavirus and MenB Vaccine Co-administration in
Not yet recruiting
- Vaccination
- +2 more
- Rotavirus Vaccine
- (no location specified)
Mar 15, 2022